Biora Therapeutics, Inc. (NASDAQ:BIOR) Q1 2024 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q1 2024 Earnings Call Transcript May 15, 2024

Biora Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.45.

Operator: Greetings and welcome to Biora Therapeutics First Quarter 2024 Financial Results Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a remainder, this conference is being recorded. I will now...